INS and Hyperglycemia: We speculated that the putative mechanism may involve L-DOPA in MSM inhibiting pancreatic insulin secretion leading to hyperglycaemia (Ericson et al. 1977) and diabetes-like inflammation of the pancreas accompanied by elevated serum amylase and lipase (Lazarus and Volk 1961; Hardt et al. 2003).